Breaking News Instant updates and real-time market news.

THO

Thor Industries

$78.54 /

-1.57 (-1.96%)

06:36
07/07/22
07/07
06:36
07/07/22
06:36

Thor Industries' Vice President of Investor Relations Mark Trinske to retire

Thor Industries announced that Mark Trinske, Vice President of Investor Relations, will be retiring at the end of the company's fiscal year on July 31. As part of the planned transition, Michael Cieslak, CFA, Thor 's Investor Relations Manager will be responsible for Thor's investor relations efforts going forward. Cieslak joined the company in February 2020 with a background in investor relations and financial planning and analysis.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Clearside Biomedical expects cash to fund operations into 2024 » 07:32
08/09/22
08/09
07:32
08/09/22
07:32
CLSD

Clearside Biomedical

$1.64 /

-0.03 (-1.80%)

As of June 30, 2022,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLSD Clearside Biomedical
$1.64 /

-0.03 (-1.80%)

CLSD Clearside Biomedical
$1.64 /

-0.03 (-1.80%)

12/22/21 Roth Capital
Roth says Clearside data 'certainly supportive' of dose-escalation in Wet AMD
12/21/21 JMP Securities
JMP remains bullish on Clearside as Cohort 2 in OASIS adds to CLS-AX potential
12/15/21 Wedbush
Clearside Biomedical assumed with an Outperform at Wedbush
10/25/21 Roth Capital
Clearside Biomedical price target raised to $17 from $15 at Roth Capital
CLSD Clearside Biomedical
$1.64 /

-0.03 (-1.80%)

Hot Stocks
Sophia Genetics sees cash runway through 2025 and beyond  07:32
08/09/22
08/09
07:32
08/09/22
07:32
SOPH

Sophia Genetics

$5.36 /

+0.9 (+20.18%)

 
ShowHide Related Items >><<
SOPH Sophia Genetics
$5.36 /

+0.9 (+20.18%)

SOPH Sophia Genetics
$5.36 /

+0.9 (+20.18%)

10/14/21 Cowen
Sophia Genetics coverage transferred at Cowen
08/17/21 Cowen
Cowen starts 'emerging leader' Sophia Genetics with Outperform
08/17/21
Fly Intel: Top five analyst initiations
08/17/21 JPMorgan
Sophia Genetics initiated with Overweight, $23 target at JPMorgan
SOPH Sophia Genetics
$5.36 /

+0.9 (+20.18%)

Earnings
Clearside Biomedical reports Q2 EPS (13c), consensus (13c) » 07:32
08/09/22
08/09
07:32
08/09/22
07:32
CLSD

Clearside Biomedical

$1.64 /

-0.03 (-1.80%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLSD Clearside Biomedical
$1.64 /

-0.03 (-1.80%)

CLSD Clearside Biomedical
$1.64 /

-0.03 (-1.80%)

12/22/21 Roth Capital
Roth says Clearside data 'certainly supportive' of dose-escalation in Wet AMD
12/21/21 JMP Securities
JMP remains bullish on Clearside as Cohort 2 in OASIS adds to CLS-AX potential
12/15/21 Wedbush
Clearside Biomedical assumed with an Outperform at Wedbush
10/25/21 Roth Capital
Clearside Biomedical price target raised to $17 from $15 at Roth Capital
CLSD Clearside Biomedical
$1.64 /

-0.03 (-1.80%)

Earnings
Sophia Genetics reports Q2 adjusted EPS (31c) vs. (31c) last year » 07:31
08/09/22
08/09
07:31
08/09/22
07:31
SOPH

Sophia Genetics

$5.36 /

+0.9 (+20.18%)

Reports Q2 revenue $11.7M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SOPH Sophia Genetics
$5.36 /

+0.9 (+20.18%)

SOPH Sophia Genetics
$5.36 /

+0.9 (+20.18%)

10/14/21 Cowen
Sophia Genetics coverage transferred at Cowen
08/17/21 Cowen
Cowen starts 'emerging leader' Sophia Genetics with Outperform
08/17/21
Fly Intel: Top five analyst initiations
08/17/21 JPMorgan
Sophia Genetics initiated with Overweight, $23 target at JPMorgan
SOPH Sophia Genetics
$5.36 /

+0.9 (+20.18%)

Downgrade
Tattooed Chef downgraded to Neutral from Buy at Roth Capital » 07:31
08/09/22
08/09
07:31
08/09/22
07:31
TTCF

Tattooed Chef

$7.76 /

+0.12 (+1.57%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TTCF Tattooed Chef
$7.76 /

+0.12 (+1.57%)

TTCF Tattooed Chef
$7.76 /

+0.12 (+1.57%)

05/10/22 Cowen
Tattooed Chef price target lowered to $13 from $18 at Cowen
12/08/21 Cowen
Tattooed Chef initiated with an Outperform at Cowen
TTCF Tattooed Chef
$7.76 /

+0.12 (+1.57%)

TTCF Tattooed Chef
$7.76 /

+0.12 (+1.57%)

Earnings
Reynolds Consumer Products sees Q3 adjusted EPS 20c-24c, consensus 43c » 07:31
08/09/22
08/09
07:31
08/09/22
07:31
REYN

Reynolds Consumer Products

$29.63 /

+0.52 (+1.79%)

Sees Q3 revenue up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REYN Reynolds Consumer Products
$29.63 /

+0.52 (+1.79%)

06/27/22 Citi
Reynolds Consumer Products price target lowered to $28 from $31 at Citi
04/13/22 Stifel
Reynolds Consumer Products downgraded to Hold at Stifel on higher input costs
04/13/22 Stifel
Reynolds Consumer Products downgraded to Hold from Buy at Stifel
03/30/22 JPMorgan
Reynolds Consumer Products price target lowered to $33 from $34 at JPMorgan
REYN Reynolds Consumer Products
$29.63 /

+0.52 (+1.79%)

REYN Reynolds Consumer Products
$29.63 /

+0.52 (+1.79%)

Earnings
InspireMD reports Q2 EPS (59c) vs (46c) last year » 07:31
08/09/22
08/09
07:31
08/09/22
07:31
NSPR

InspireMD

$2.05 /

+0.045 (+2.25%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NSPR InspireMD
$2.05 /

+0.045 (+2.25%)

NSPR InspireMD
$2.05 /

+0.045 (+2.25%)

05/11/22 Alliance Global Partners
InspireMD price target lowered to $5.25 from $9 at Alliance Global Partners
03/01/22 Alliance Global Partners
InspireMD price target lowered to $9 from $16.50 at Alliance Global Partners
NSPR InspireMD
$2.05 /

+0.045 (+2.25%)

Downgrade
Turtle Beach downgraded to Perform on weaker outlook at Oppenheimer » 07:30
08/09/22
08/09
07:30
08/09/22
07:30
HEAR

Turtle Beach

$14.00 /

-0.145 (-1.03%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

07:26 Today Wedbush
Turtle Beach price target lowered to $12 from $22 at Wedbush
06:38 Today Oppenheimer
Turtle Beach downgraded to Perform from Outperform at Oppenheimer
08/04/22 Wedbush
Turtle Beach price target lowered to $22 from $27 at Wedbush
07/06/22 DA Davidson
Turtle Beach price target lowered to $25 from $30 at DA Davidson
HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

Earnings
Vertex sees 2022 revenue $480M-$484M, consensus $481.26M » 07:30
08/09/22
08/09
07:30
08/09/22
07:30
VERX

Vertex

$12.69 /

+0.83 (+7.00%)

Cloud revenue growth of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VERX Vertex
$12.69 /

+0.83 (+7.00%)

VERX Vertex
$12.69 /

+0.83 (+7.00%)

07/14/22 Morgan Stanley
Vertex price target lowered to $10 from $12 at Morgan Stanley
05/23/22 Jefferies
Vertex price target lowered to $13.50 from $14.50 at Jefferies
03/10/22 Needham
Vertex price target lowered to $19 from $30 at Needham
03/10/22 JMP Securities
Vertex price target lowered to $28 from $36 at JMP Securities
VERX Vertex
$12.69 /

+0.83 (+7.00%)

  • 12
    Jan
Earnings
BioXcel Therapeutics reports Q2 EPS ($1.35), consensus ($1.22) » 07:29
08/09/22
08/09
07:29
08/09/22
07:29
BTAI

BioXcel Therapeutics

$16.61 /

+0.15 (+0.91%)

As of June 30, 2022, cash…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BTAI BioXcel Therapeutics
$16.61 /

+0.15 (+0.91%)

BTAI BioXcel Therapeutics
$16.61 /

+0.15 (+0.91%)

07/08/22 Canaccord
BioXcel Therapeutics significant room for upside seen, says Canaccord
07/06/22 Mizuho
BioXcel Therapeutics initiated with a Buy at Mizuho
05/23/22 H.C. Wainwright
BioXcel Therapeutics price target lowered to $110 from $134 at H.C. Wainwright
05/13/22 Canaccord
BioXcel Therapeutics price target lowered to $75 from $84 at Canaccord
BTAI BioXcel Therapeutics
$16.61 /

+0.15 (+0.91%)

BTAI BioXcel Therapeutics
$16.61 /

+0.15 (+0.91%)

Earnings
Avrobio reports Q2 EPS (64c) vs.(74c) » 07:29
08/09/22
08/09
07:29
08/09/22
07:29
AVRO

Avrobio

$1.00 /

+0.0061 (+0.62%)

As of June 30, AVROBIO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVRO Avrobio
$1.00 /

+0.0061 (+0.62%)

AVRO Avrobio
$1.00 /

+0.0061 (+0.62%)

05/11/22 Wedbush
Avrobio price target lowered to $4 from $14 at Wedbush
05/11/22 Barclays
Avrobio price target lowered to $4 from $6 at Barclays
01/06/22 Mizuho
Avrobio price target lowered to $6 from $28 at Mizuho
01/05/22 Morgan Stanley
Avrobio price target lowered to $3 from $7 at Morgan Stanley
AVRO Avrobio
$1.00 /

+0.0061 (+0.62%)

Earnings
Reynolds Consumer Products reports Q2 adjusted EPS 26, consensus 25c » 07:29
08/09/22
08/09
07:29
08/09/22
07:29
REYN

Reynolds Consumer Products

$29.63 /

+0.52 (+1.79%)

Reports Q2 revenue $917M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REYN Reynolds Consumer Products
$29.63 /

+0.52 (+1.79%)

06/27/22 Citi
Reynolds Consumer Products price target lowered to $28 from $31 at Citi
04/13/22 Stifel
Reynolds Consumer Products downgraded to Hold at Stifel on higher input costs
04/13/22 Stifel
Reynolds Consumer Products downgraded to Hold from Buy at Stifel
03/30/22 JPMorgan
Reynolds Consumer Products price target lowered to $33 from $34 at JPMorgan
REYN Reynolds Consumer Products
$29.63 /

+0.52 (+1.79%)

REYN Reynolds Consumer Products
$29.63 /

+0.52 (+1.79%)

Earnings
Vertex sees Q3 revenue $121.5M-$124M, consensus $122.86M » 07:29
08/09/22
08/09
07:29
08/09/22
07:29
VERX

Vertex

$12.69 /

+0.83 (+7.00%)

Adjusted EBITDA of $16.5…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VERX Vertex
$12.69 /

+0.83 (+7.00%)

VERX Vertex
$12.69 /

+0.83 (+7.00%)

07/14/22 Morgan Stanley
Vertex price target lowered to $10 from $12 at Morgan Stanley
05/23/22 Jefferies
Vertex price target lowered to $13.50 from $14.50 at Jefferies
03/10/22 Needham
Vertex price target lowered to $19 from $30 at Needham
03/10/22 JMP Securities
Vertex price target lowered to $28 from $36 at JMP Securities
VERX Vertex
$12.69 /

+0.83 (+7.00%)

  • 12
    Jan
Downgrade
Charter downgraded to Hold from Buy at Argus » 07:28
08/09/22
08/09
07:28
08/09/22
07:28
CHTR

Charter

/

+

Argus analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHTR Charter
/

+

CHTR Charter
/

+

07:12 Today Argus
Charter downgraded to Hold from Buy at Argus
08/01/22 Morgan Stanley
Charter price target lowered to $550 from $600 at Morgan Stanley
08/01/22 Deutsche Bank
Charter price target lowered to $550 from $575 at Deutsche Bank
08/01/22 Barclays
Charter downgraded to Underweight from Equal Weight at Barclays
CHTR Charter
/

+

CHTR Charter
/

+

CHTR Charter
/

+

CHTR Charter
/

+

Initiation
Tenaz Energy resumed with a Speculative Buy at Stifel » 07:28
08/09/22
08/09
07:28
08/09/22
07:28
ATUUF

Tenaz Energy

$1.45 /

+ (+0.00%)

Stifel analyst Robert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATUUF Tenaz Energy
$1.45 /

+ (+0.00%)

10/25/21 Stifel
Tenaz Energy downgraded to Speculative Buy from Buy at Stifel
Recommendations
Monday.com price target raised to $180 from $150 at Cowen » 07:28
08/09/22
08/09
07:28
08/09/22
07:28
MNDY

Monday.com

$150.67 /

+22.83 (+17.86%)

Cowen analyst J. Derrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MNDY Monday.com
$150.67 /

+22.83 (+17.86%)

MNDY Monday.com
$150.67 /

+22.83 (+17.86%)

08/08/22 Jefferies
Monday.com price target raised to $140 from $115 at Jefferies
07/18/22 Piper Sandler
Monday.com price target lowered to $150 from $200 at Piper Sandler
06/01/22 Tigress Financial
Monday.com price target lowered to $240 from $432 at Tigress Financial
05/17/22 Cowen
Monday.com price target lowered to $200 from $240 at Cowen
MNDY Monday.com
$150.67 /

+22.83 (+17.86%)

MNDY Monday.com
$150.67 /

+22.83 (+17.86%)

Earnings
Vertex reports Q2 EPS 6c vs. 8c last year » 07:28
08/09/22
08/09
07:28
08/09/22
07:28
VERX

Vertex

$12.69 /

+0.83 (+7.00%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VERX Vertex
$12.69 /

+0.83 (+7.00%)

VERX Vertex
$12.69 /

+0.83 (+7.00%)

07/14/22 Morgan Stanley
Vertex price target lowered to $10 from $12 at Morgan Stanley
05/23/22 Jefferies
Vertex price target lowered to $13.50 from $14.50 at Jefferies
03/10/22 Needham
Vertex price target lowered to $19 from $30 at Needham
03/10/22 JMP Securities
Vertex price target lowered to $28 from $36 at JMP Securities
VERX Vertex
$12.69 /

+0.83 (+7.00%)

  • 12
    Jan
Recommendations
Qualys price target lowered to $150 from $160 at Wedbush » 07:28
08/09/22
08/09
07:28
08/09/22
07:28
QLYS

Qualys

$127.37 /

-0.695 (-0.54%)

Wedbush analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QLYS Qualys
$127.37 /

-0.695 (-0.54%)

QLYS Qualys
$127.37 /

-0.695 (-0.54%)

08/08/22 Summit Insights
Qualys sentiment to improve as revenue accelerates, says Summit Insights
07/26/22 Truist
Qualys price target raised to $125 from $115 at Truist
07/15/22 DA Davidson
Qualys initiated with a Neutral at DA Davidson
04/11/22 Wolfe Research
Qualys initiated with an Outperform at Wolfe Research
QLYS Qualys
$127.37 /

-0.695 (-0.54%)

QLYS Qualys
$127.37 /

-0.695 (-0.54%)

QLYS Qualys
$127.37 /

-0.695 (-0.54%)

Earnings
Cerence sees FY22 revenue $322M-$328M, consensus $370.89M » 07:28
08/09/22
08/09
07:28
08/09/22
07:28
CRNC

Cerence

$29.76 /

+0.36 (+1.22%)

Sees FY22 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRNC Cerence
$29.76 /

+0.36 (+1.22%)

CRNC Cerence
$29.76 /

+0.36 (+1.22%)

07/07/22 RBC Capital
Cerence upgraded to Sector Perform from Underperform at RBC Capital
05/18/22 Northland
SoundHound replacing Cerence at Hyundai, says Northland
05/11/22 Craig-Hallum
Cerence price target lowered to $45 from $52 at Craig-Hallum
05/11/22 Wedbush
Cerence price target lowered to $32 from $45 at Wedbush
CRNC Cerence
$29.76 /

+0.36 (+1.22%)

Earnings
Cerence sees Q4 revenue $52M-$58M, consensus $98.46M » 07:28
08/09/22
08/09
07:28
08/09/22
07:28
CRNC

Cerence

$29.76 /

+0.36 (+1.22%)

Q4 adjusted EBITDA is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRNC Cerence
$29.76 /

+0.36 (+1.22%)

CRNC Cerence
$29.76 /

+0.36 (+1.22%)

07/07/22 RBC Capital
Cerence upgraded to Sector Perform from Underperform at RBC Capital
05/18/22 Northland
SoundHound replacing Cerence at Hyundai, says Northland
05/11/22 Craig-Hallum
Cerence price target lowered to $45 from $52 at Craig-Hallum
05/11/22 Wedbush
Cerence price target lowered to $32 from $45 at Wedbush
CRNC Cerence
$29.76 /

+0.36 (+1.22%)

Earnings
Healthcare Realty Trust reports Q2 normalized FFO 45c, consensus 45c » 07:27
08/09/22
08/09
07:27
08/09/22
07:27
HR

Healthcare Realty Trust

$25.35 /

+0.24 (+0.96%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HR Healthcare Realty Trust
$25.35 /

+0.24 (+0.96%)

HR Healthcare Realty Trust
$25.35 /

+0.24 (+0.96%)

05:03 Today Citi
Healthcare Realty Trust resumed with a Neutral at Citi
07/21/22 JPMorgan
Healthcare Realty Trust reinstated with a Neutral at JPMorgan
07/18/22 Credit Suisse
Healthcare Realty Trust price target lowered to $29 from $34 at Credit Suisse
06/03/22 Capital One
Healthcare Realty Trust reinstated with an Overweight at Capital One
HR Healthcare Realty Trust
$25.35 /

+0.24 (+0.96%)

HR Healthcare Realty Trust
$25.35 /

+0.24 (+0.96%)

HR Healthcare Realty Trust
$25.35 /

+0.24 (+0.96%)

Earnings
Blade Air Mobility reports Q2 revenue $35.63M, consensus $37.98M » 07:27
08/09/22
08/09
07:27
08/09/22
07:27
BLDE

Blade Air Mobility

$6.22 /

+0.095 (+1.55%)

Reports Q2 flight margin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BLDE Blade Air Mobility
$6.22 /

+0.095 (+1.55%)

BLDE Blade Air Mobility
$6.22 /

+0.095 (+1.55%)

05/12/22 Deutsche Bank
Blade Air Mobility price target lowered to $10 from $15 at Deutsche Bank
02/08/22 JPMorgan
JPMorgan sees revenue beat for Blade Air Mobility on Thursday
01/31/22 Citi
Blade Air Mobility price target lowered to $13 from $16 at Citi
12/21/21 Oppenheimer
Blade Air Mobility price target lowered to $13 from $14 at Oppenheimer
BLDE Blade Air Mobility
$6.22 /

+0.095 (+1.55%)

BLDE Blade Air Mobility
$6.22 /

+0.095 (+1.55%)

Recommendations
Turtle Beach price target lowered to $12 from $22 at Wedbush » 07:26
08/09/22
08/09
07:26
08/09/22
07:26
HEAR

Turtle Beach

$14.00 /

-0.145 (-1.03%)

Wedbush analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

06:38 Today Oppenheimer
Turtle Beach downgraded to Perform from Outperform at Oppenheimer
08/04/22 Wedbush
Turtle Beach price target lowered to $22 from $27 at Wedbush
07/06/22 DA Davidson
Turtle Beach price target lowered to $25 from $30 at DA Davidson
05/17/22 Wedbush
Wedbush upgrades Turtle Beach to Outperform on higher chance of deal
HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

Hot Stocks
Nuvei sees 30%+ annual y-o-y growth for total volume in the medium term » 07:26
08/09/22
08/09
07:26
08/09/22
07:26
NVEI

Nuvei

$42.06 /

+4.555 (+12.15%)

Sees 30%+ annual y-o-y…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVEI Nuvei
$42.06 /

+4.555 (+12.15%)

NVEI Nuvei
$42.06 /

+4.555 (+12.15%)

07/22/22 Credit Suisse
Nuvei downgraded to Neutral from Outperform at Credit Suisse
07/20/22 JPMorgan
Nuvei price target lowered to $63 from $65 at JPMorgan
07/14/22 Goldman Sachs
Nuvei downgraded to Neutral from Buy at Goldman Sachs
05/11/22 Canaccord
Nuvei price target lowered to $85 from $110 at Canaccord
NVEI Nuvei
$42.06 /

+4.555 (+12.15%)

  • 06
    Oct
NVEI Nuvei
$42.06 /

+4.555 (+12.15%)

Hot Stocks
Reata Pharmaceuticals: FDA extends review timeline for NDA for omaveloxolone » 07:26
08/09/22
08/09
07:26
08/09/22
07:26
RETA

Reata Pharmaceuticals

$24.02 /

-11.895 (-33.12%)

"Reata…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

06:49 Today Baird
Reata Pharmaceuticals price target lowered to $27 from $37 at Baird
08/08/22 Goldman Sachs
Reata sinks on Friedreich's ataxia update but Goldman remains positive
08/08/22 Goldman Sachs
Reata Pharmaceuticals price target raised to $76 from $73 at Goldman Sachs
05/27/22 Citi
Reata Pharmaceuticals price target raised to $46 from $43 at Citi
RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.